Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2014 Aug 10;23(8):2110–2116. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.025

Table 2.

Estimated Hazard Ratios and 95% Confidence Intervals for the Association between Sleep Medication Use and Stroke Risk

Models

Medication Type 1
Demographic
2
+ SES
3
+ Risk Factor
4
+ Mental Health
5
+ Apnea
OTC 1.52** (1.11 – 2.09) 1.52** (1.11 – 2.09) 1.52* (1.09 – 2.12) 1.52* (1.09 – 2.12) 1.52* (1.09 – 2.11)
Prescription 1.11 (0.76 – 1.62) 1.10 (0.75 – 1.60) 0.89 (0.59 – 1.36) 0.88 (0.57 – 1.34) 0.89 (0.58 – 1.35)
Either 1.31 ǂ (1.00 – 1.73) 1.31 ǂ (0.99 – 1.72) 1.22 (0.91 – 1.63) 1.21 (0.90 – 1.62) 1.21 (0.90 – 162)

Demographic = age, race, sex; + SES = income, education; + Risk Factors = systolic blood pressure, antihypertensive use, diabetes, current smoking, left ventricular hypertrophy, atrial fibrillation, heart disease; + Mental Health = Center for Epidemiological Studies – Depression 4-item form, Perceived Stress Scale score; + Apnea = diagnosed sleep apnea, apnea risk on the Berlin Questionnaire; OTC = over-the-counter sleeping pills; REGARDS = REasons for Geographic and Racial Differences in Stroke

**

p < 0.01;

*

p < 0.05;

ǂ

p < 0.06